|
|
Anti-cancer drug that protects against blindness
Doctors discovered, in some cases, a coincidence given the benefit of drug to a patient suffering from a particular disease, to heal it from another disease, and this is what actually happened with the anti-cancer drug called Comeritastaten A-4.
According to the Journal Abotiki Rudenscao German was by chance in a medical research institutes in Washington to reach this medicine pioneer, which can prevent the infection of millions of people blinded full or partial, and has proven its effectiveness after it conducted hundreds of experiments on animals and people living with cancer in early stages, but At the same time and vulnerable to health reasons injured a condition called "squint molecular wet." A disease resulting from the multiplication of abnormal blood cells behind the retina that allows fluid leak, causing a scar tissue, and leading to the destruction of central vision.
The disease affects strabismus Aldzia wet in some cases, older people with diabetes is very advanced. But take the healing process of the disease that the patient is not aware of it but he has cancer, it takes two months to two years. The researchers have developed a drug "Comeritastaten" primarily to prevent the growth and proliferation of tumors by preventing the blood supply it, but realized later that it can be used to prevent the disease, which threatens to blind eyes.
But it is important to address this disease if it appears just before the stage of a pond vessels in the eyes, so the periodic examination at the age above sixty is very necessary to detect the disease early and avoid the loss of sight. The symptoms of discomfort of light and blurred vision of the first symptoms by the warning of injury, in addition to injury, glaucoma (glaucoma) and cataracts (cataract) and diabetic retinopathy.
Interestingly, the drug Comeritastaten A-4, which is used to treat cancer and now for the treatment of strabismus Aldzia wet, is derived from the organic molecule called "Comeritam Ccaffram" extracted from the bark of the willow tree African, and proved effective in tests conducted killer active cells to cancerous tumors.
Doctors discovered, in some cases, a coincidence given the benefit of drug to a patient suffering from a particular disease, to heal it from another disease, and this is what actually happened with the anti-cancer drug called Comeritastaten A-4.
According to the Journal Abotiki Rudenscao German was by chance in a medical research institutes in Washington to reach this medicine pioneer, which can prevent the infection of millions of people blinded full or partial, and has proven its effectiveness after it conducted hundreds of experiments on animals and people living with cancer in early stages, but At the same time and vulnerable to health reasons injured a condition called "squint molecular wet." A disease resulting from the multiplication of abnormal blood cells behind the retina that allows fluid leak, causing a scar tissue, and leading to the destruction of central vision.
The disease affects strabismus Aldzia wet in some cases, older people with diabetes is very advanced. But take the healing process of the disease that the patient is not aware of it but he has cancer, it takes two months to two years. The researchers have developed a drug "Comeritastaten" primarily to prevent the growth and proliferation of tumors by preventing the blood supply it, but realized later that it can be used to prevent the disease, which threatens to blind eyes.
But it is important to address this disease if it appears just before the stage of a pond vessels in the eyes, so the periodic examination at the age above sixty is very necessary to detect the disease early and avoid the loss of sight. The symptoms of discomfort of light and blurred vision of the first symptoms by the warning of injury, in addition to injury, glaucoma (glaucoma) and cataracts (cataract) and diabetic retinopathy.
Interestingly, the drug Comeritastaten A-4, which is used to treat cancer and now for the treatment of strabismus Aldzia wet, is derived from the organic molecule called "Comeritam Ccaffram" extracted from the bark of the willow tree African, and proved effective in tests conducted killer active cells to cancerous tumors.
0 Comments:
Post a Comment